Dicerna Pharma (DRNA) Tops Q2 EPS by 9c

Dicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($0.75), $0.09 better than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.

You May Also Be Interested In

• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• Estee Lauder (EL) Tops Q4 EPS by 7c, Beats on Revenue
• ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c